The Hematology Diagnostics Market is expected to reach US$ 264 Mn during the forecast period at a 5% CAGR.
The key factors that have helped expand hematology diagnostics market share includes rise in focus of effective diagnosis and higher cases of blood disorders in developing and developed economies. According to statistics, blood cancers such as lymphoma, myeloma or leukemia affected billion people in the U.S. alone. Growing awareness about these conditions among patients and healthcare professionals have expanded the global hematology diagnostics market size. Besides that, higher adoption of point-of-care testing methods and technological advancements results in easy-to-use devices and accurate results. However, the market may hamper with lower awareness among developing economies and huge cost of automated and advanced instruments.
Based on regions, the global hematology diagnostics market is classified into Europe, Asia-Pacific, the Americas and the Middle East and Africa. The Americas is sub-divided into South America and North America. The North American region is further classified into Canada and the U.S. The European region is sub-divided into Eastern Europe and Western Europe. Western Europe is further categories that is inclusive of France, Germany, Italy, Spain, the UK, and the rest of Western Europe. The Asia-Pacific region is sub-divided Japan, the Republic of Korea, China, India, Australia and the rest of Asia-Pacific. African and the Middle Eastern region is sub-segmented into the Saudi Arabia, United Arab Emirates, Kuwait, Oman, Qatar, and the rest of the Middle East and Africa.
global hematology diagnostics market is classified on the basis of tests, product type and end-user. Based on product type, the hematology diagnostics market has different categories which include flow cytometers, consumables and hematology analyzers. Hematology analyzers category is further divided into semi-automated and fully-automated hematology analyzers. segment of consumables includes controls, reagents, stains, calibrators, and others. Tests category has further classification which is inclusive of anemia, hemoglobinopathy, hematology pathophysiology, complete blood count (CBC), leukemia/lymphoma phenotyping, and others. Based on end-user, the market is divided into ambulatory surgical centers, hospitals and clinics, academic institutes, diagnostic laboratories and others.
The global hematology diagnostics market share is anticipated to experience expansion. Key leading players such as Sysmex Corporation, F. Hoffmann-La Roche Ltd., Abbott Laboratories and Beckman Coulter, Inc. have strong presence in the hematology diagnostics market. In the recent past years, hematology diagnostics market has experienced huge investments by multinational manufacturers such as Sysmex Corporation, Abbott Laboratories and F. Hoffmann-La Roche Ltd. The market has witnessed strong demand for laboratory consolidation and automation in order to enhance efficiency and precision, and advancement in technology resulting in easy usage. For instance, Danaher in April 2018 received CE Mark of its DxH 520 hematology analyzer, which is developed to support physician office laboratories. Another instance, Roche declared the launch of the new hematology testing solution in January 2017 which was given name the Cobas m 511 integrated hematology analyzer. It incorporates a distinctive way through patented Bloodhound technology for staining, imaging and printing.
Key segments of ‘Global Hematology Diagnostics Market’
Based on product type, the market has been segmented into,
- Hematology Analyzers
- Fully-automated Hematology Analyzers
- Semi-automated Hematology Analyzers
- Flow Cytometers
- Controls & Calibrators
Based on tests, the market has been segmented into,
- Leukemia/Lymphoma Phenotyping
- Hematology pathophysiology
- Complete blood count (CBC)
Based on region, the market has been segmented into,
- Middle East & Africa